|Author (Corporate)||European Commission: DG Health and Food Safety|
|Series Details||COM (2020) 761|
Communication published by the European Commission on 25 November 2020, setting out a strategy for the pharmaceutical sector in the European Union (EU).
This strategy aims to create a future-proof regulatory framework and support industry in promoting research and technologies that actually reach patients and fulfil their therapeutic needs while addressing market failures. It also takes into account the weaknesses exposed by the COVID-19 (coronavirus) pandemic and factor-in appropriate actions to strengthen the system.
Europe's Pharmaceutical Strategy has four main objectives:
This strategy is a component of the so-called European Health Union, as called for by the President of the European Commission during her 2020 State of the European Union address. It was presented to the European Parliament on 26 November.
|Subject Categories||Business and Industry, Culture, Education and Research, Health, Internal Markets|
|Subject Tags||Medicines | Medical Devices, Pharmaceuticals, Public Health|
|Keywords||Antimicrobial Resistance, Innovation
|International Organisations||European Union [EU]|